본문 바로가기
KERD
논문KCI 등재

위샘암 환자의 예후 인자로서 Thymosin-β4의 용성

Prognostic Significance of Thymosin-β4 in GastricAdenocarcinoma Patients

1

조회

0

다운로드

1

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : Thymosin-β4 is an actin-sequestering protein that regulates actin polymerization. It is known to be associated with cell migration, angiogenesis and wound healing, as well as with tumor metastasis. Methods : We immunohistochemically evaluated the thymosin-β4 expression in gastric adenocarcinoma specimens, the relationship between this protein and the pathologic features and other tumor-related proteins, and its influence on the patient outcome. Results : We demonstrated that 40 specimens (26.3%) of 152 gastric adenocarcinomas showed positivity for thymosin-β4. The thymosin-β4 expression was statistically associated with advanced tumor stage (p=0.010), the nodal stage (p=0.029), the TNM stage (p= 0.008), and the presence of lymphovascular invasion (p=0.009). The thymosin-β4 protein expression was closely related to the positivity for VEGF (p=0.000), c-Myc (p=0.007), and cyclin D1 (p=0.005), but it was not associated with the E-cadherin (p=0.861) or β-catenin (p= 0.640) expressions. The median survival and disease relapse time of patients showing thymosin-β4 immunoreactivity were statistically shorter than those of patients without expression. Multivariate analysis showed that the tumor stage (p=0.003), nodal stage (p=0.005), thymosin-β4 expression (p=0.019) and Lauren's classification (p=0.037) were statistically important prognostic factors for gastric adenocarcinomas. Conclusions : The thymosin-β4 expression might be associated with disease progression of gastric adenocarcinomas and it should be regarded as an important prognostic factor for estimating patient survival.

참고문헌 (27)

  1. "Tumors of the stomach", pp.39~52 (2000), Lyon: IARCPress
  2. "The neoplastic stomach", pp.237~274 (1998), Philadelphia: Lippincott-
  3. "Motility of rat ascites hepatomacells with reference to malignant characteristics in cancermetastasis", pp.273~6
  4. "Genomic analysis of metastasisreveals an essential role for RhoC", 406, pp.532~535 (2000)
  5. "Isolation of a 5-kilodalton actin-sequesteringpeptide from human blood platelets", pp.2536~40
  6. "Thymosin 4sequesters the majority of G-actin in resting human polymorphonuclearleukocytes", pp.1261~70
  7. "Thymosin beta4 accelerateswound healing", 113, pp.364~368 (1999)
  8. "Thymosin beta4 stimulatesdirectional migration of human umbilical vein endothelial cells", 11, pp.474~481 (1997)
  9. "Overexpression of thethymosin beta4 gene is associated with malignant progression ofSW480 colon cancer cells", 22, pp.3297~3306 (2003)
  10. "Thymosin-beta4 regulates motilityand metastasis of malignant mouse fibrosarcoma cells", 160, pp.869~882 (2002)
  11. "Thymosin 10 gene overexpressionis a general event in human carcinogenesis", 155, pp.799~804 (1999)
  12. "Preliminaryfindings on the expression of thymosin beta-10 in human breast cancer", 74, pp.1441~1444 (1996)
  13. "Differential expression of thymosin genes in human tumours and in the developing human kidney", pp.672~7
  14. "Overexpressionof the thymosin 4 gene is associated with increasedinvasion of SW40 colon carcinoma cells and the distant metastasisof human colorectal carcinoma", 23, pp.6666~6671 (2004)
  15. "Thymosin beta 15: A novel regulator of tumor cell motility upregulatedin metastatic prostate cancer", 2, pp.1322~1328 (1996)
  16. "Thymosin beta15 expression in tumor celllines with varying metastatic potential", 16, pp.227~233 (1998)
  17. "Role of thymosin 4 in tumor metastasisand angiogenesis", 95, pp.1674~1680 (2003)
  18. "Thymosin beta4 enhances endothelial differentiation and angiogenesis", 3, pp.125~135 (1999)
  19. "Role of thymosin beta4 in tumormetastasis and angiogenesis", 85, pp.1674~1680 (2003)
  20. "Ellis LM.Significance of vessel count and vascular endothelial growth factorand its receptor (KDR) in intestinal-type gastric cancer", 2, pp.1679~1684 (1996)
  21. "Prognostic value of vascularendothelial growth factor expression in gastric carcinoma", 77, pp.858~863 (1996)
  22. "p53 and VEGF expression areindependent predictors of tumor recurrence and survival followingcurative resection of gastric cancer", 90, pp.206~215 (2004)
  23. "Interleukin 8 and vascular endothelialgrowth factor-prognostic factors in human gastric carcinoma?", 37, pp.1482~1487 (2001)
  24. "Bright-Tomas RM, Hargest R", 29, pp.107~117 (2003)
  25. "Malat-1, a novel noncoding RNA,and thymosin 4 predict metastasis and survival in early-stage nonsmallcell lung cancer", 22, pp.6087~6097 (2003)
  26. "Selective nonsteroidalanti-inflammatory drugs induce thymosin 4 and alteractin cytoskeletal organization in human colorectal cancer cells", 311, pp.885~891 (2004)
  27. "Overexpression of thymosin 4renders SW480 colon carcinoma cells more resistant to apoptosistriggered by FasL and two topoisomerase II inhibitors via downregulatingFas and upregulating Survivin expression, respectively", 27, pp.936~944 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (13건)